Low-dose dexamethasone during arthroplasty: What do we know about the risks?

EFORT Open Reviews

article

Jessica T. Wegener¹  Tim Kraal²  Markus F. Stevens¹  Markus W. Hollmann¹  Gino M.M.J. Kerkhoffs²  Daniël Haverkamp² 

[1] Department of Anesthesiology, Academic Medical Center (AMC), University of Amsterdam;Department of Orthopedic Surgery, Academic Medical Center and the Orthopedic Research Center Amsterdam

关键词: rthroplasty;    hip;    knee;    post-operative nausea and vomiting;    PONV;    surgical site infections;    SSI;   

DOI  :  10.1302/2058-5241.1.000039

学科分类：神经科学

来源: The British Editorial Society of Bone & Joint Surgery

【 摘 要 】

In the last decade, many improvements in the peri-operative management of patients undergoing arthroplasty have facilitated the initiation of fast-track surgery, shortening the length of hospital stay up to 60%.1 A substantial part of the shortened hospital stay is related to improved peri-operative pain management and prevention of postoperative nausea and vomiting (PONV), resulting in faster mobilisation and discharge of patients. Meanwhile, many peri-operative strategies in preventing surgical site infections (SSI) after arthroplasty have been taken. Currently, conflicting views among orthopaedic surgeons and anaesthesiologists raise doubts on the use of dexamethasone during joint arthroplasty surgery.

【 授权许可】

CC BY|CC BY-NC|CC BY-NC-ND